Richard Mayeux is a Neurology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 1,253 publications with 117,400 citations (h-index 158); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
710 W 168th St
New York, NY 100323726
Telephone
212-305-2391Registry record last updated 30 May 2012.
Clinical trials
- Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
Sponsor: New York State Psychiatric Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor100%Donepezil Hcl100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
32 NIH research awards on record, funded 1985–2026 per NIH RePORTER. The latest:
- National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS)
Columbia University Health Sciences
FY2026$4,153,919U24AG056270 - SORL1 and its involvement in Alzheimer's disease pathogenesis and pathophysiology - Genetics Core
Columbia University Health Sciences
FY2026$280,999P01AG090268 - National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS)
Columbia University Health Sciences
FY2025$4,491,049U24AG056270
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Kevin Clerkin, MD
NewYork–Presbyterian Hospital
Brandon Swed, MD
NewYork–Presbyterian Hospital
Lawrence Lenke, MD
NewYork–Presbyterian Hospital
Manuel Hidalgo Medina, MD
NewYork–Presbyterian Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”